Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I)

Area of Science:

• Neurology
• Virology
• Immunology

Background:

• Progressive spastic paraparesis (PSP) is a neurological disorder affecting middle-aged women.
• The etiology of PSP remains largely unknown, necessitating further investigation into potential infectious or autoimmune links.

Purpose of the Study:

• To investigate the association between human T-cell leukemia virus type I (HTLV-I) infection and progressive spastic paraparesis (PSP) in a Chilean population.
• To characterize the clinical, immunological, and neurophysiological findings in HTLV-I positive PSP patients.

Main Methods:

• Case collection of 83 PSP patients over three years (1987-1990).
• Serological testing for anti-HTLV-I antibodies using enzyme-linked immunosorbent assay (ELISA) and western blot.
• Cerebrospinal fluid (CSF) analysis, including cell count and immunoglobulin G (IgG) index.
• Neurophysiological assessments: somatosensory evoked potentials (SEPs).
• Neuropsychological evaluations using the Wechsler Adult Intelligence Scale (WAIS).

Main Results:

• 54.2% of PSP patients tested positive for anti-HTLV-I antibodies in CSF and blood.
• Among seropositive patients, 35.7% showed mononuclear pleocytosis, 66.6% had an increased IgG index, and abnormalities in CD2 and CD4 cell counts were observed.
• Delayed latency in somatosensory evoked potentials (90.9%) and impaired cognitive functions (mean verbal IQ 80.7, performance IQ 84.8) were noted.
• HTLV-I antibodies were also detected in 18.9% of relatives of seropositive PSP cases.

Conclusions:

• A significant proportion of progressive spastic paraparesis cases in Chile are associated with HTLV-I infection.
• HTLV-I infection may play a role in the pathogenesis of PSP, potentially through immune system activation and neurological damage.
• Further research is warranted to elucidate the precise mechanisms linking HTLV-I to PSP and to explore potential therapeutic interventions.